Cancer is a difficult disease to treat because it is hard to detect within the body. Cancer sneaks in to normal cells and changes them to cancer cells over time. The immune system mistakes cancer cells for healthy cells, so they are not attacked.
Quantifying the DNA Damage Response in Clinical Grade Pluripotent Stem Cells; An Efficient, Highly Sensitive Means of Establishing a Quality Control Standard in Large Scale Pluripotent Stem Cell Production.
For years, embryonic stem (ES) cells have shown great promise in helping to stimulate our body’s own ability to heal, but there are limitations to using these cells. Oftentimes, ES cells are rejected by the body’s immune system because they are not native to the body. There is another type of stem cell, though, that lack these compatibility issues.